/People

Amber Cai

Investor

Venture Partner at F-Prime Capital

Cambridge

Find your path to Amber

Sign up to see every warm intro you have to Amber

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Amber. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Venture Partner at F-Prime focused on early-stage biotechnology investments, and founding CEO of gene and cell therapy company Skyline Therapeutics. She was previously a founding member and Head of Operations of Novartis' R&D Center in China, holds a PhD from MIT in GPCR signaling, and an MBA from MIT Sloan.

Invests in

Biotech

Colleagues at F-Prime Capital

Frequently asked questions

Who is Amber Cai?
Venture Partner at F-Prime focused on early-stage biotechnology investments, and founding CEO of gene and cell therapy company Skyline Therapeutics. She was previously a founding member and Head of Operations of Novartis' R&D Center in China, holds a PhD from MIT in GPCR signaling, and an MBA from MIT Sloan.
Where does Amber Cai work?
Amber Cai is Venture Partner at F-Prime Capital.
What does Amber Cai invest in?
Amber Cai invests in Biotech.

About this profile. Compiled from public sources — F-Prime Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights